• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测乳腺癌新辅助化疗病理完全缓解的跨模态深度学习模型。

Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer.

作者信息

Guo Jianming, Chen Baihui, Cao Hongda, Dai Quan, Qin Ling, Zhang Jinfeng, Zhang Youxue, Zhang Huanyu, Sui Yuan, Chen Tianyu, Yang Dongxu, Gong Xue, Li Dalin

机构信息

Department of Breast Surgery, Harbin Medical University Cancer Hospital, 150000, Harbin, China.

School of Computer, Beihang University, 100191, Beijing, China.

出版信息

NPJ Precis Oncol. 2024 Sep 5;8(1):189. doi: 10.1038/s41698-024-00678-8.

DOI:10.1038/s41698-024-00678-8
PMID:39237596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11377584/
Abstract

Pathological complete response (pCR) serves as a critical measure of the success of neoadjuvant chemotherapy (NAC) in breast cancer, directly influencing subsequent therapeutic decisions. With the continuous advancement of artificial intelligence, methods for early and accurate prediction of pCR are being extensively explored. In this study, we propose a cross-modal multi-pathway automated prediction model that integrates temporal and spatial information. This model fuses digital pathology images from biopsy specimens and multi-temporal ultrasound (US) images to predict pCR status early in NAC. The model demonstrates exceptional predictive efficacy. Our findings lay the foundation for developing personalized treatment paradigms based on individual responses. This approach has the potential to become a critical auxiliary tool for the early prediction of NAC response in breast cancer patients.

摘要

病理完全缓解(pCR)是衡量乳腺癌新辅助化疗(NAC)成功与否的关键指标,直接影响后续治疗决策。随着人工智能的不断发展,早期准确预测pCR的方法正在被广泛探索。在本研究中,我们提出了一种整合时空信息的跨模态多途径自动预测模型。该模型融合活检标本的数字病理图像和多时间点超声(US)图像,以在NAC早期预测pCR状态。该模型显示出卓越的预测效能。我们的研究结果为基于个体反应制定个性化治疗模式奠定了基础。这种方法有可能成为乳腺癌患者NAC反应早期预测的关键辅助工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/e6540087020f/41698_2024_678_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/4b7052027e29/41698_2024_678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/76c5e52916da/41698_2024_678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/fd20df9b3bc9/41698_2024_678_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/e39600cfe405/41698_2024_678_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/1333e62cd322/41698_2024_678_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/0328db1bef72/41698_2024_678_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/e6540087020f/41698_2024_678_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/4b7052027e29/41698_2024_678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/76c5e52916da/41698_2024_678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/fd20df9b3bc9/41698_2024_678_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/e39600cfe405/41698_2024_678_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/1333e62cd322/41698_2024_678_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/0328db1bef72/41698_2024_678_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d5e/11377584/e6540087020f/41698_2024_678_Fig7_HTML.jpg

相似文献

1
Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer.用于预测乳腺癌新辅助化疗病理完全缓解的跨模态深度学习模型。
NPJ Precis Oncol. 2024 Sep 5;8(1):189. doi: 10.1038/s41698-024-00678-8.
2
A hierarchical self-attention-guided deep learning framework to predict breast cancer response to chemotherapy using pre-treatment tumor biopsies.基于层次化自注意力引导的深度学习框架,利用预处理肿瘤活检预测乳腺癌对化疗的反应。
Med Phys. 2023 Dec;50(12):7852-7864. doi: 10.1002/mp.16574. Epub 2023 Jul 5.
3
Deep learning-based predictive model for pathological complete response to neoadjuvant chemotherapy in breast cancer from biopsy pathological images: a multicenter study.基于深度学习的乳腺癌活检病理图像对新辅助化疗病理完全缓解的预测模型:一项多中心研究
Front Physiol. 2024 Jan 31;15:1279982. doi: 10.3389/fphys.2024.1279982. eCollection 2024.
4
Dual-Branch Convolutional Neural Network Based on Ultrasound Imaging in the Early Prediction of Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Breast Cancer.基于超声成像的双分支卷积神经网络在局部晚期乳腺癌患者新辅助化疗反应早期预测中的应用
Front Oncol. 2022 Apr 7;12:812463. doi: 10.3389/fonc.2022.812463. eCollection 2022.
5
Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer.基于深度学习的乳腺癌新辅助化疗病理完全缓解预测生物标志物的组织学图像。
J Transl Med. 2021 Aug 16;19(1):348. doi: 10.1186/s12967-021-03020-z.
6
Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.基于治疗前超声的深度学习影像组学模型用于早期预测乳腺癌新辅助化疗的病理反应
Eur Radiol. 2023 Aug;33(8):5634-5644. doi: 10.1007/s00330-023-09555-7. Epub 2023 Mar 28.
7
Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.超声深度学习影像组学用于全面预测乳腺癌患者新辅助化疗后的肿瘤及腋窝淋巴结状态:一项多中心研究
Cancer. 2023 Feb 1;129(3):356-366. doi: 10.1002/cncr.34540. Epub 2022 Nov 19.
8
Ultrasound and diffuse optical tomography-transformer model for assessing pathological complete response to neoadjuvant chemotherapy in breast cancer.超声与漫射光学断层成像-Transformer 模型评估乳腺癌新辅助化疗的病理完全缓解。
J Biomed Opt. 2024 Jul;29(7):076007. doi: 10.1117/1.JBO.29.7.076007. Epub 2024 Jul 24.
9
Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.使用深度学习(DL)方法预测乳腺癌新辅助化疗的病理完全缓解。
Thorac Cancer. 2020 Mar;11(3):651-658. doi: 10.1111/1759-7714.13309. Epub 2020 Jan 16.
10
Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.基于连体多任务网络的HER2阳性乳腺癌患者纵向超声图像对新辅助化疗治疗反应的早期预测:一项多中心回顾性队列研究
EClinicalMedicine. 2022 Jul 30;52:101562. doi: 10.1016/j.eclinm.2022.101562. eCollection 2022 Oct.

引用本文的文献

1
Artificial Intelligence-Based Pathology to Assist Prediction of Neoadjuvant Therapy Responses for Breast Cancer.基于人工智能的病理学辅助预测乳腺癌新辅助治疗反应
Cancer Med. 2025 Aug;14(15):e71132. doi: 10.1002/cam4.71132.
2
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.用于预测乳腺癌新辅助治疗结果的多模态深度学习:一项系统综述
Biol Direct. 2025 Jun 23;20(1):72. doi: 10.1186/s13062-025-00661-8.
3
Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer.

本文引用的文献

1
CrossFormer++: A Versatile Vision Transformer Hinging on Cross-Scale Attention.CrossFormer++:一种基于跨尺度注意力的通用视觉Transformer
IEEE Trans Pattern Anal Mach Intell. 2024 May;46(5):3123-3136. doi: 10.1109/TPAMI.2023.3341806. Epub 2024 Apr 3.
2
Impact of Imaging Biomarkers and AI on Breast Cancer Management: A Brief Review.影像生物标志物与人工智能对乳腺癌管理的影响:简要综述
Cancers (Basel). 2023 Oct 30;15(21):5216. doi: 10.3390/cancers15215216.
3
Platinum-based chemotherapy for early triple-negative breast cancer.
基于纵向磁共振成像的多模态方法预测乳腺癌病理完全缓解及B细胞浸润
Adv Sci (Weinh). 2025 Mar;12(12):e2413702. doi: 10.1002/advs.202413702. Epub 2025 Feb 7.
含铂化疗治疗早期三阴性乳腺癌。
Cochrane Database Syst Rev. 2023 Sep 8;9(9):CD014805. doi: 10.1002/14651858.CD014805.pub2.
4
Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study.基于超声和临床病理特征的模型预测 HER2 阳性乳腺癌新辅助化疗的病理反应:一项病例对照研究。
Breast Cancer Res Treat. 2023 Nov;202(1):45-55. doi: 10.1007/s10549-023-07057-0. Epub 2023 Aug 28.
5
A hierarchical self-attention-guided deep learning framework to predict breast cancer response to chemotherapy using pre-treatment tumor biopsies.基于层次化自注意力引导的深度学习框架,利用预处理肿瘤活检预测乳腺癌对化疗的反应。
Med Phys. 2023 Dec;50(12):7852-7864. doi: 10.1002/mp.16574. Epub 2023 Jul 5.
6
DSMT-Net: Dual Self-Supervised Multi-Operator Transformation for Multi-Source Endoscopic Ultrasound Diagnosis.DSMT-Net:用于多源内镜超声诊断的双自监督多算子变换。
IEEE Trans Med Imaging. 2024 Jan;43(1):64-75. doi: 10.1109/TMI.2023.3289859. Epub 2024 Jan 2.
7
Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.基于治疗前超声的深度学习影像组学模型用于早期预测乳腺癌新辅助化疗的病理反应
Eur Radiol. 2023 Aug;33(8):5634-5644. doi: 10.1007/s00330-023-09555-7. Epub 2023 Mar 28.
8
Automated Molecular Subtyping of Breast Carcinoma Using Deep Learning Techniques.基于深度学习技术的乳腺癌自动分子分型。
IEEE J Transl Eng Health Med. 2023 Feb 6;11:161-169. doi: 10.1109/JTEHM.2023.3241613. eCollection 2023.
9
Vision-Transformer-Based Transfer Learning for Mammogram Classification.基于视觉Transformer的乳房X光照片分类迁移学习
Diagnostics (Basel). 2023 Jan 4;13(2):178. doi: 10.3390/diagnostics13020178.
10
ATFE-Net: Axial Transformer and Feature Enhancement-based CNN for ultrasound breast mass segmentation.ATFE-Net:用于超声乳腺肿块分割的基于轴向Transformer和特征增强的卷积神经网络
Comput Biol Med. 2023 Feb;153:106533. doi: 10.1016/j.compbiomed.2022.106533. Epub 2023 Jan 3.